Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.034
Filter
1.
Vet Res ; 55(1): 78, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38877574

ABSTRACT

Endoplasmic reticulum stress (ERS) and oxidative stress (OS) are adaptive responses of the body to stressor stimulation. Although it has been verified that Trichinella spiralis (T. spiralis) can induce ERS and OS in the host, their association is still unclear. Therefore, this study explored whether T. spiralis-secreted serpin-type serine protease inhibitor (TsAdSPI) is involved in regulating the relationship between ERS and OS in the host intestine. In this study, mice jejunum and porcine small intestinal epithelial cells (IECs) were detected using qPCR, western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and detection kits. The results showed that ERS- and OS-related indexes changed significantly after TsAdSPI stimulation, and Bip was located in IECs, indicating that TsAdSPI could induce ERS and OS in IECs. After the use of an ERS inhibitor, OS-related indexes were inhibited, suggesting that TsAdSPI-induced OS depends on ERS. When the three ERS signalling pathways, ATF6, IRE1, and PERK, were sequentially suppressed, OS was only regulated by the PERK pathway, and the PERK-eif2α-CHOP-ERO1α axis played a key role. Similarly, the expression of ERS-related indexes and the level of intracellular Ca2+ were inhibited after adding the OS inhibitor, and the expression of ERS-related indexes decreased significantly after inhibiting calcium transfer. This finding indicated that TsAdSPI-induced OS could affect ERS by promoting Ca2+ efflux from the endoplasmic reticulum. The detection of the ERS and OS sequences revealed that OS occurred before ERS. Finally, changes in apoptosis-related indexes were detected, and the results indicated that TsAdSPI-induced ERS and OS could regulate IEC apoptosis. In conclusion, TsAdSPI induced OS after entering IECs, OS promoted ERS by enhancing Ca2+ efflux, and ERS subsequently strengthened OS by activating the PERK-eif2α-CHOP-ERO1α axis. ERS and OS induced by TsAdSPI synergistically promoted IEC apoptosis. This study provides a foundation for exploring the invasion mechanism of T. spiralis and the pathogenesis of host intestinal dysfunction after invasion.


Subject(s)
Endoplasmic Reticulum Stress , Epithelial Cells , Oxidative Stress , Serpins , Trichinella spiralis , Animals , Endoplasmic Reticulum Stress/drug effects , Trichinella spiralis/physiology , Mice , Oxidative Stress/drug effects , Swine , Serpins/metabolism , Serpins/genetics , Serine Proteinase Inhibitors/pharmacology , Helminth Proteins/metabolism , Helminth Proteins/genetics , Jejunum/drug effects
2.
BMC Cancer ; 24(1): 758, 2024 Jun 24.
Article in English | MEDLINE | ID: mdl-38914961

ABSTRACT

BACKGROUND: Colon cancer (CC) is a malignancy associated with significant morbidity and mortality within the gastrointestinal tract. Recurrence and metastasis are the main factors affecting the prognosis of CC patients undergoing radical surgery; consequently, we attempted to determine the impact of immunity-related genes. RESULT: We constructed a CC risk model based on ZG16, MPC1, RBM47, SMOX, CPM and DNASE1L3. Consistently, we found that a significant association was found between the expression of most characteristic genes and tumor mutation burden (TMB), microsatellite instability (MSI) and neoantigen (NEO). Additionally, a notable decrease in RBM47 expression was observed in CC tissues compared with that in normal tissues. Moreover, RBM47 expression was correlated with clinicopathological characteristics and improved disease-free survival (DFS) and overall survival (OS) among patients with CC. Lastly, immunohistochemistry and co-immunofluorescence staining revealed a clear positive correlation between RBM47 and CXCL13 in mature tertiary lymphoid structures (TLS) region. CONCLUSION: We conclude that RBM47 was identified as a prognostic-related gene, which was of great significance to the prognosis evaluation of patients with CC and was correlated with CXCL13 in the TLS region.


Subject(s)
Biomarkers, Tumor , Colonic Neoplasms , Microsatellite Instability , Humans , Colonic Neoplasms/genetics , Colonic Neoplasms/immunology , Colonic Neoplasms/pathology , Colonic Neoplasms/mortality , Prognosis , Male , Female , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Middle Aged , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Aged , Mutation , Gene Expression Regulation, Neoplastic , Disease-Free Survival
3.
J Nat Med ; 2024 Jun 27.
Article in English | MEDLINE | ID: mdl-38926328

ABSTRACT

Alzheimer's disease (AD) remains a challenging neurodegenerative disorder with limited therapeutic success. Traditional Chinese Medicine (TCM), as a promising new source for AD, still requires further exploration to understand its complex components and mechanisms. Here, focused on addressing Aß (1-40) aggregation, a hallmark of AD pathology, we employed a Thioflavin T fluorescence labeling method for screening the active molecular library of TCM which we established. Among the eight identified, 1,3-di-caffeoylquinic acid emerged as the most promising, exhibiting a robust binding affinity with a KD value of 26.7 nM. This study delves into the molecular intricacies by utilizing advanced techniques, including two-dimensional (2D) 15N-1H heteronuclear single quantum coherence nuclear magnetic resonance (NMR) and molecular docking simulations. These analyses revealed that 1,3-di-caffeoylquinic acid disrupts Aß (1-40) self-aggregation by interacting with specific phenolic hydroxyl and amino acid residues, particularly at Met-35 in Aß (1-40). Furthermore, at the cellular level, the identified compounds, especially 1,3-di-caffeoylquinic acid, demonstrated low toxicity and exhibited therapeutic potential by regulating mitochondrial membrane potential, reducing cell apoptosis, and mitigating Aß (1-40)-induced cellular damage. This study presents a targeted exploration of catechol compounds with implications for effective interventions in AD and sheds light on the intricate molecular mechanisms underlying Aß (1-40) aggregation disruption.

4.
Int J Infect Dis ; : 107118, 2024 Jun 13.
Article in English | MEDLINE | ID: mdl-38878994

ABSTRACT

OBJECTIVES: To determine the efficacy and safety of respiratory syncytial virus (RSV) vaccines in infants and older adults. METHODS: We performed a systematic review and meta-analysis of randomized control trials that evaluated the efficacy of maternal RSV immunization against infections in infants, as well as the efficacy of RSV vaccines in older adults. The primary outcome was the vaccine efficacy against RSV-related lower respiratory tract disease (LRTD). GRADE criteria was used to evaluate the level of evidence. RESULTS: Ten trials were included in the review. For maternal vaccination, the RSV vaccine showed favourable efficacy against RSV-related LRTD (vaccine efficacy 57.3%, 95% CI 31.3 to 73.5; low certainty) and RSV-related severe LRTD (vaccine efficacy 81.9%, 95% CI 56.8 to 92.4; moderate certainty) in infants within 90 days after birth. For older adults, Meta-analysis showed that RSV vaccines could also reduce the risk of RSV-related LRTD (vaccine efficacy 78.3%, 95% CI 65.6 to 86.3; moderate certainty) and RSV-related severe LRTD (vaccine efficacy 86.5%, 95% CI 68.3 to 94.3; moderate certainty). There was no significant difference in serious adverse events between RSV vaccines and placebo. CONCLUSION: RSV vaccines have the potential to offer protection against RSV disease in both infants and older adults, without apparent safety concerns.

5.
Chin Med J (Engl) ; 2024 Jun 20.
Article in English | MEDLINE | ID: mdl-38902199

ABSTRACT

BACKGROUND: The optimal antidepressant dosages remain controversial. This study aimed to analyze the efficacy of antidepressants and characterize their dose-response relationships in the treatments of major depressive disorders (MDD). METHODS: We searched multiple databases, including the Embase, Cochrane Central Register of Controlled Trials, PubMed, and Web of Science, for the studies that were conducted between January 8, 2016, and April 30, 2023. The studies are double-blinded, randomized controlled trials (RCTs) involving the adults (≥18 years) with MDD. The primary outcomes were efficacy of antidepressant and the dose-response relationships. A frequentist network meta-analysis was conducted, treating participants with various dosages of the same antidepressant as a single therapy. We also implemented the model-based meta-analysis (MBMA) using a Bayesian method to explore the dose-response relationships. RESULTS: The network meta-analysis comprised 135,180 participants from 602 studies. All the antidepressants were more effective than the placebo; toludesvenlafaxine had the highest odds ratio (OR) of 4.52 (95% confidence interval [CI]: 2.65-7.72), and reboxetine had the lowest OR of 1.34 (95%CI: 1.14-1.57). Moreover, amitriptyline, clomipramine, and reboxetine showed a linear increase in effect size from low to high doses. The effect size of toludesvenlafaxine increased significantly up to 80 mg/day and subsequently maintained the maximal dose up to 160 mg/day while the predictive curves of nefazodone were fairly flat in different dosages. CONCLUSIONS: Although most antidepressants were more efficacious than placebo in treating MDD, no consistent dose-response relationship between any antidepressants was observed. For most antidepressants, the maximum efficacy was achieved at lower or middle prescribed doses, rather than at the upper limit.

6.
PLoS One ; 19(6): e0304819, 2024.
Article in English | MEDLINE | ID: mdl-38905246

ABSTRACT

Solar cells are playing a significant role in aerospace equipment. In view of the surface defect characteristics in the manufacturing process of solar cells, the common surface defects are divided into three categories, which include difficult-detecting defects (mismatch), general defects (bubble, glass-crack and cell-crack) and easy-detecting defects (glass-upside-down). Corresponding to different types of defects, the deep learning model with different optimization methods and a classification detection method based on multi-models fusion are proposed in the paper. In the proposed model, in order to solve the mismatch problem between the default anchor boxes size of YOLOv5s model and the extreme scale of the battery mismatch defect label boxes, the K-means algorithm was adopted to re-cluster the dedicated anchor boxes for the mismatch defect label boxes. In order to improve the comprehensive detection accuracy of YOLOv5s model for the general defects, the YOLOv5s model was also improved by the methods of image preprocessing, anchor box improving and detection head replacing. In order to ensure the recognition accuracy and improve the detection speed for easy-detecting defects, the lightweight classification network MobileNetV2 was also used to classify the cells with glass-upside-down defects. The experimental results show that the proposed optimization model and classification detection method can significantly improve the defect detection precision. Respectively, the detection precision for mismatch, bubble, glass-crack and cell-crack defects are up to 95.64%, 91.8%, 93.1% and 98.0%. By using lightweight model to train the glass-upside-down defect dataset, the average classification accuracy reaches 100% and the detection speed reaches 13.29 frames per second. The comparison experiments show that the proposed model has a great improvement in detection accuracy compared with the original model, and the defect detection speed of lightweight classification network is improved more obviously, which confirms the effectiveness of the proposed optimization model and the multi-defect classification detection method for solar cells defect detection.


Subject(s)
Deep Learning , Solar Energy , Algorithms , Image Processing, Computer-Assisted/methods
7.
Traffic Inj Prev ; : 1-9, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38875466

ABSTRACT

OBJECTIVE: The visual guiding system, as a tunnel traffic safety improvement method by using visual guiding facilities to actively guide driving safely, has been widely used in countries with many tunnels, in recent years. This paper aims to quantitatively study the comprehensive evaluation of traffic safety of the visual guiding system in tunnels, which has certain engineering application value and can provide support for the quantitative evaluation and optimal design of tunnel traffic safety. METHODS: Based on the analysis of the relevant factors of urban tunnel traffic safety, a multi-factor comprehensive evaluation system with 5 upper-level indicators and 12 basic-level indicators was proposed. Considering the independent and incompatible indicators, a comprehensive evaluation method of traffic safety of the visual guiding system in urban tunnels was constructed by using the extension matter-element model. Taking the scene of 4 types of tunnel curves, such as no facilities, horizontal stripe, chevron alignment sign, and LED arch, as examples, the comprehensive evaluation of various schemes were carried out by using simulation tests. RESULTS: The traffic safety comprehensive evaluation system of visual guiding system in urban tunnels can be analyzed from five aspects: perception reaction, guidance ability, driver factor, driving task, and facility appearance. The results demonstrated significant the comprehensive evaluation result of the target level of scene 1 was L4, scene 2 was L3, scene 3 was L2, and scene 4 was L1. That is, the final results of the comprehensive evaluation of the four scenes were poor, medium, good, and very good, respectively. CONCLUSIONS: In the scheme of visual guiding system for urban tunnel curves, the effectiveness of the three types of designs, from high to low, was the LED arch, chevron alignment sign, and horizontal stripe, and the safety of the scene without facilities was the lowest. Hence, setting the LED arch in the urban tunnel curve has a good effect in the aspects of guidance ability, sight distance, and sight zone, and is conducive to the driver's perception reaction and driving task.

8.
Sci Rep ; 14(1): 14560, 2024 06 24.
Article in English | MEDLINE | ID: mdl-38914572

ABSTRACT

Azole antifungal drugs are commonly used to treat vulvovaginal candidiasis (VVC). The nephrotoxicity and developmental toxicity of azole drugs have not been systematically analyzed in the real world. We used the FDA Adverse Event Reporting System (FAERS) to investigate the adverse events (AEs) associated with imidazole therapy for VVC. FAERS data (from quarter 1 2004 to quarter 3 2022) were retrieved using OpenVigil 2.1, and AEs were retrieved and standardized according to the Medical Dictionary for Regulatory Activities (MedDRA). In the top 10 System Organ Class (SOC), all four drugs have been found to have kidney and urinary system diseases and pregnancy. We found significant signals, including clotrimazole [bladder transitional cell carcinoma, (report odds ratio, ROR = 291.66)], [fetal death, (ROR = 10.28)], ketoconazole[nephrogenic anemia (ROR = 22.1)], [premature rupture of membranes (ROR = 22.91 46.45, 11, 3)], Miconazole[hematuria (ROR = 19.03)], [neonatal sepsis (ROR = 123.71)], [spontaneous abortion (ROR = 5.98)], Econazole [acute kidney injury (ROR = 4.41)], [spontaneous abortion (ROR = 19.62)]. We also discovered new adverse reactions that were not reported. Therefore, when using imidazole drugs for treatment, it is necessary to closely monitor the patient's renal function, pay attention to the developmental toxicity of the fetus during pregnancy, and be aware of potential adverse reactions that may occur.


Subject(s)
Adverse Drug Reaction Reporting Systems , Antifungal Agents , Candidiasis, Vulvovaginal , Imidazoles , United States Food and Drug Administration , Female , Humans , Candidiasis, Vulvovaginal/drug therapy , Antifungal Agents/adverse effects , Antifungal Agents/therapeutic use , Imidazoles/adverse effects , United States , Pregnancy , Adult , Drug-Related Side Effects and Adverse Reactions/epidemiology , Miconazole/adverse effects , Miconazole/administration & dosage , Clotrimazole/adverse effects
9.
Diabetes Obes Metab ; 2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38888056

ABSTRACT

AIM: To evaluate the real-world effectiveness of automated insulin delivery (AID) systems in patients with type 1 diabetes (T1D). MATERIALS AND METHODS: PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov were searched for studies published up until 2 March 2024. We included pragmatic randomized controlled trials (RCTs), cohort studies, and before-after studies that compared AID systems with conventional insulin therapy in real-world settings and reported continuous glucose monitoring outcomes. Percent time in range (TIR; 3.9-10 mmol/L), time below range (TBR; <3.9 mmol/L), time above range (TAR; >10 mmol/L), and glycated haemoglobin (HbA1c) level were extracted. Data were summarized as mean differences (MDs) with 95% confidence interval. RESULTS: A total of 23 before-after studies (101 704 participants) were included in the meta-analysis. AID systems were associated with an increased percentage of TIR (11.61%, 10.47 to 12.76; p < 0.001). The favourable effect of AID systems was consistently observed when used continuously for 6 (11.76%) or 12 months (11.33%), and in both children (12.16%) and adults (11.04%). AID systems also showed favourable effects on TBR (-0.53%, -0.63 to -0.42), TAR (-9.65%, -10.63 to -8.67) and HbA1c level (-0.42%, -0.47 to -0.37) when compared with previous treatments. CONCLUSIONS: Similar improvements in glycaemic parameters were observed in real-world settings in RCTs using AID systems in T1D. AID systems benefit both children and adults by increasing TIR for both short- and long-term interventions.

10.
Front Immunol ; 15: 1406234, 2024.
Article in English | MEDLINE | ID: mdl-38868780

ABSTRACT

Objective: This study employed Mendelian Randomization (MR) to investigate the causal relationships among immune cells, COPD, and potential metabolic mediators. Methods: Utilizing summary data from genome-wide association studies, we analyzed 731 immune cell phenotypes, 1,400 plasma metabolites, and COPD. Bidirectional MR analysis was conducted to explore the causal links between immune cells and COPD, complemented by two-step mediation analysis and multivariable MR to identify potential mediating metabolites. Results: Causal relationships were identified between 41 immune cell phenotypes and COPD, with 6 exhibiting reverse causality. Additionally, 21 metabolites were causally related to COPD. Through two-step MR and multivariable MR analyses, 8 cell phenotypes were found to have causal relationships with COPD mediated by 8 plasma metabolites (including one unidentified), with 1-methylnicotinamide levels showing the highest mediation proportion at 26.4%. Conclusion: We have identified causal relationships between 8 immune cell phenotypes and COPD, mediated by 8 metabolites. These findings contribute to the screening of individuals at high risk for COPD and offer insights into early prevention and the precocious diagnosis of Pre-COPD.


Subject(s)
Genome-Wide Association Study , Mendelian Randomization Analysis , Pulmonary Disease, Chronic Obstructive , Pulmonary Disease, Chronic Obstructive/blood , Pulmonary Disease, Chronic Obstructive/immunology , Pulmonary Disease, Chronic Obstructive/genetics , Humans , Phenotype , Biomarkers/blood , Polymorphism, Single Nucleotide , Metabolome , Genetic Predisposition to Disease
11.
Beijing Da Xue Xue Bao Yi Xue Ban ; 56(3): 424-430, 2024 Jun 18.
Article in Chinese | MEDLINE | ID: mdl-38864127

ABSTRACT

OBJECTIVE: To assess the safety of sitagliptin added to metformin on cardiovascular adverse events in real world patients with type 2 diabetes mellitus (T2DM). METHODS: Real world data from Yinzhou Regional Health Care Database were used to select T2DM patients with diagnosis and treatment records in the platform from January 1, 2017 to December 31, 2022. According to drug prescription records, the patients were divided into metformin plus sitagliptin group (combination group) and metformin monotherapy group(monotherapy group). A series of retrospective cohorts were constructed according to the index date.Finally, full retrospective cohorts were constructed according to propensity score model, including baseline covariates that might be related to outcomes, to match the subjects in the combination group and monotherapy group for the purpose of increasing the comparability of baseline characteristics. The participants were followed up from the index date until the first occurrence of the following events: Diagnosis of outcomes, death, or the end of the study period (December 31, 2022). Cox proportional risk model was used to estimate the hazard ratio(HR)and 95% confidence interval (CI) of sitagliptin added to metformin on 3-point major adverse cardiovascular events (3P-MACE) combination outcome and secondary cardiovascular outcomes. RESULTS: Before propensity score matching, the proportion of the patients in combination group using insulin, α glucosidase inhibitors, sodium-glucose transporter 2 inhibitors (SGLT-2I) and glienides at baseline was higher than that in monotherapy group, and the baseline fasting blood glucose (FBG) and hemoglobin A1c (HbA1c) levels in combination group were higher than those in monotherapy group. After propensity score matching, 5 416 subjects were included in the combination group and the monotherapy group, and baseline characteristics were effectively balanced between the groups. The incidence densities of 3P-MACE were 6.41/100 person years and 6.35/100 person years, respectively. Sitagliptin added to metformin did not increase or decrease the risk of 3P-MACE compared with the metformin monotherapy (HR=1.00, 95% CI: 0.91-1.10). In secondary outcomes analysis, the incidence of cardiovascular death was lower in the combination group than in the monotherapy group (HR=0.59, 95% CI: 0.41-0.85), and no association was found between sitagliptin and the risk of myocardial infarction and stroke (HR=1.12, 95% CI: 0.89-1.41; HR=0.99, 95% CI: 0.91-1.12). CONCLUSION: In T2DM patients in Yinzhou district of Ningbo, compared with metformin alone, sitagliptin added to metformin may reduce the risk of cardiovascular death, and do not increase the incidence of overall cardiovascular events. The results of this study can provide real-world evidence for post-marketing cardiovascular safety evaluation of sitagliptin.


Subject(s)
Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Drug Therapy, Combination , Hypoglycemic Agents , Metformin , Sitagliptin Phosphate , Humans , Diabetes Mellitus, Type 2/drug therapy , Sitagliptin Phosphate/adverse effects , Sitagliptin Phosphate/therapeutic use , Sitagliptin Phosphate/administration & dosage , Metformin/adverse effects , Metformin/therapeutic use , Metformin/administration & dosage , Retrospective Studies , Hypoglycemic Agents/adverse effects , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Male , Female , Cardiovascular Diseases/prevention & control , Middle Aged , Propensity Score , Proportional Hazards Models , Aged
12.
Water Res ; 258: 121753, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38754298

ABSTRACT

Seawater utilization is crucial for the sustainable human development. Despite growing interest in forward osmosis (FO) due to its unique properties, conventional FO membranes with salt-water selectivity have limitations in applying to specific salt-salt separation processes, which hinders their application in resource utilization. In this work, a new concept, "selective forward osmosis (SFO)", was proposed, which ingeniously employed an SFO membrane consisting of an ion-selective layer on a denser substrate. The denser substrate is designed to control water flux so as to alleviate the solution dilution and improve the salt-salt separation. Moreover, the sucrose and pure water were used separately as feed solution to provide different water flux to influence the various salt fluxes, showing that pure water feed could enhance the salt-salt separation efficiency, although it could dilute the draw solution to some extent. Therefore, pure water was selected as feed in the subsequent experiments. The optimized SFO membrane achieved high Na2SO4/NaCl selectivity (∼54.8) and MgCl2/NaCl selectivity (∼9.2) in single-salt draw solutions. With mixed-salt and heavy-metal-mixed-salt draw solutions, the Mg2+/Na+ selectivity was enhanced to ∼14.5, and further to 29.3. In real seawater tests, the SFO system effectively permeated monovalent elements (such as Na flux of ∼68.6 g m-2 h-1) while maintaining a higher rejection for bivalent elements (such as Mg flux of ∼0.08 g m-2 h-1), showing high selectivities for Mg/Na, U/Na, Sr/Na, Ni/Na, and Ca/Na. These results demonstrate the potential of SFO for resource utilization, especially in complex saline environments. This work contributes a new route for salt-salt separation in the pretreatment of seawater resources.


Subject(s)
Osmosis , Seawater , Sodium Chloride , Seawater/chemistry , Sodium Chloride/chemistry , Membranes, Artificial , Water Purification/methods
14.
Int J Biol Macromol ; 271(Pt 1): 132520, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38772463

ABSTRACT

Blocking the tumor nutrient supply through angiogenic inhibitors is an effective treatment approach for malignant tumors. However, using angiogenic inhibitors alone may not be enough to achieve a significant tumor response. Therefore, we recently designed a universal drug delivery system combining chemotherapy and anti-angiogenic therapy to target tumor cells while minimizing drug-related side effects. This system (termed as PCCE) is composed of biomaterial chondroitin sulfate (CS), the anti-angiogenic peptide ES2, and paclitaxel (PTX), which collectively enhance antitumor properties. Interestingly, the PCCE system is conferred exceptional cell membrane permeability due to inherent characteristics of CS, including CD44 receptor-mediated endocytosis. The PCCE could respond to the acidic and high glutathione conditions, thereby releasing PTX and ES2. PCCE could effectively inhibit the proliferation, migration, and invasion of tumor cells and cause apoptosis, while PCCE can affect the endothelial cells tube formation and exert anti-angiogenic function. Consistently, more potent in vivo antitumor efficacy and non-toxic sides were demonstrated in B16F10 xenograft mouse models. PCCE can achieve excellent antitumor activity via modulating angiogenic and apoptosis-related factors. In summary, we have successfully developed an intelligent and responsive CS-based nanocarrier known as PCCE for delivering various antitumor drugs, offering a promising strategy for treating malignant tumors.


Subject(s)
Angiogenesis Inhibitors , Chondroitin Sulfates , Nanoparticles , Paclitaxel , Chondroitin Sulfates/chemistry , Chondroitin Sulfates/pharmacology , Paclitaxel/pharmacology , Paclitaxel/administration & dosage , Paclitaxel/chemistry , Paclitaxel/therapeutic use , Animals , Angiogenesis Inhibitors/pharmacology , Angiogenesis Inhibitors/chemistry , Angiogenesis Inhibitors/therapeutic use , Angiogenesis Inhibitors/administration & dosage , Humans , Mice , Nanoparticles/chemistry , Cell Line, Tumor , Apoptosis/drug effects , Xenograft Model Antitumor Assays , Cell Proliferation/drug effects , Drug Carriers/chemistry , Cell Movement/drug effects , Neovascularization, Pathologic/drug therapy , Human Umbilical Vein Endothelial Cells/drug effects , Drug Delivery Systems , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/administration & dosage
15.
Fish Shellfish Immunol ; 150: 109622, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38740227

ABSTRACT

The voltage-dependent anion channel 2 (VDAC2) is the abundant protein in the outer mitochondrial membrane. Opening VDAC2 pores leads to the induction of mitochondrial energy and material transport, facilitating interaction with various mitochondrial proteins implicated in essential processes such as cell apoptosis and proliferation. To investigate the VDAC2 in lower vertebrates, we identified Lr-VDAC2, a homologue of VDAC2 found in lamprey (Lethenteron reissneri), sharing a sequence identity of greater than 50 % with its counterparts. Phylogenetic analysis revealed that the position of Lr-VDAC2 aligns with the lamprey phylogeny, indicating its evolutionary relationship within the species. The Lr-VDAC2 protein was primarily located in the mitochondria of lamprey cells. The expression of the Lr-VDAC2 protein was elevated in high energy-demanding tissues, such as the gills, muscles, and myocardial tissue in normal lampreys. Lr-VDAC2 suppressed H2O2 (hydrogen peroxide)-induced 293 T cell apoptosis by reducing the expression levels of Caspase 3, Caspase 9, and Cyt C (cytochrome c). Further research into the mechanism indicated that the Lr-VDAC2 protein inhibited the pro-apoptotic activity of BAK (Bcl-2 antagonist/killer) protein by downregulating its expression at the protein translational level, thus exerting an anti-apoptotic function similar to the role of VDAC2 in humans.


Subject(s)
Apoptosis , Down-Regulation , Fish Proteins , Hydrogen Peroxide , Lampreys , Voltage-Dependent Anion Channel 2 , bcl-2 Homologous Antagonist-Killer Protein , Animals , Voltage-Dependent Anion Channel 2/genetics , Apoptosis/drug effects , Lampreys/genetics , Lampreys/immunology , bcl-2 Homologous Antagonist-Killer Protein/genetics , bcl-2 Homologous Antagonist-Killer Protein/metabolism , Humans , Down-Regulation/drug effects , Fish Proteins/genetics , Fish Proteins/immunology , HEK293 Cells , Gene Expression Regulation/drug effects , Phylogeny , Sequence Alignment/veterinary , Amino Acid Sequence , Gene Expression Profiling/veterinary
16.
Clin Pharmacol Ther ; 2024 May 09.
Article in English | MEDLINE | ID: mdl-38724461

ABSTRACT

Model-based meta-analysis (MBMA) can be used in assisting drug development and optimizing treatment in clinical practice, potentially reducing costs and accelerating drug approval. We aimed to assess the application and quality of MBMA studies. We searched multiple databases to identify MBMA in pharmaceutical research. Eligible MBMA should incorporate pharmacological concepts to construct mathematical models and quantitatively examine and/or predict drug effects. Relevant information was summarized to provide an overview of the application of MBMA. We used AMSTAR-2 and PRISMA 2020 checklists to evaluate the methodological and reporting quality of included MBMA, respectively. A total of 143 MBMA studies were identified. MBMA was increasingly used over time for one or more areas: drug discovery and translational research (n = 8, 5.6%), drug development decision making (n = 42, 29.4%), optimization of clinical trial design (n = 46, 32.2%), medication in special populations (n = 15, 10.5%), and rationality and safety of drug use (n = 71, 49.7%). The included MBMA covered 17 disease areas, with the top three being nervous system diseases (n = 19, 13.2%), endocrine/nutritional/metabolic diseases (n = 17, 11.8%), and neoplasms (n = 16, 11.1%). Of these MBMA studies, 138 (96.5%) were rated as very low quality. The average rate of compliance with PRISMA was only 51.4%. Our findings suggested that MBMA was mainly used to evaluate the efficacy and safety of drugs, with a focus on chronic diseases. The methodological and reporting quality of MBMA should be further improved. Given AMSTAR-2 and PRISMA checklists were not specifically designed for MBMA, adapted assessment checklists for MBMA should be warranted.

17.
Biomater Res ; 28: 0020, 2024.
Article in English | MEDLINE | ID: mdl-38715911

ABSTRACT

Cerebral ischemia was one of the leading causes of mortality and disability worldwide. Extracellular matrix (ECM) hydrogel held great potential to replace volumetric brain tissue loss following ischemic injury but with limited regenerative effect for functional restoration when implanted alone. In the present study, an engineered basic fibroblast growth factor (EBP-bFGF) was constructed, which fused a specific ECM-binding peptide (EBP peptide) with bFGF. The recombinant EBP-bFGF showed typical binding capacity with ECM without affecting the bioactivity of bFGF both in vitro and in vivo. Furthermore, the EBP-bFGF was used for bioactive modification of ECM hydrogel to repair cerebral ischemia. The combination of EBP-bFGF and ECM hydrogels could realize the sustained release of bFGF in the ischemic brain and improve the regenerative effect of ECM, which protected the survival of neurons, enhanced angiogenesis, and decreased the permeability of blood-brain barrier, ultimately promoted the recovery of motor function. In addition, transcriptome analysis revealed neuregulin-1/AKT pathway involved in this process. Therefore, EBP-bFGF/ECM hydrogel would be a promising therapeutic strategy for cerebral ischemia.

18.
Heliyon ; 10(9): e30344, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38726112

ABSTRACT

Background: Major depressive disorder (MDD) is a widespread health issue in many countries, which has an extremely negative impact on the health of children and adolescents in particular. In the context of depression and metabolic disorders, dyslipidemia and metabolism-related problems become more prominent comorbidities. However, they continue to be the main barrier to the successful recovery of the clinical progress. In this study we investigated the rate of dyslipidemia, additional risk factors among Chinese children and adolescents with MDD, and association of the suicidal behavior with lipid levels. Methods: The study took 756 people from the Third People's Hospital of Fuyang between January 2020 and December 2021, aged between 8 and 18, with major depressive disorders diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). We determined the FBG (fasting blood glucose) and lipid parameters in all subjects and also investigated the history of suicidal ideation, the cases of attempted suicide, and the scores of depressive symptoms. Sociodemographic and clinical data were gathered and analyzed using the SPSS-23.0 version. Results: The prevalence of hypercholesterolemia, hypertriglyceridemia, high LDL-C, and low HDL-C were 5.42 % (41/756), 10.58 % (80/756), 3.84 % (29/756) and 5.42 % (41/756) respectively. For hypercholesterolemia and hypertriglyceridemia, they were positive associated with suicidal ideation and suicide attempts, and the positive correlation is shown between low HDL-C levels and suicide attempts. Nevertheless, non-ideation and inversely suicidal attempts were not discovered among high-LDL-C subjects. Logistic analysis showed that high levels of FBG (OR = 2.86, 95 % CI: 1.31-6.25, P = 0.008) and worse LDL-C (OR = 357.82, 95 % CI: 66.16-1935.10, P < 0.001) are the independent associated factors for hypercholesterolemia. More hospitalizations (OR = 1.89, 95 % CI: 1.07-3.35, P = 0.028), obesity (OR = 2.55, 95 % CI: 1.25-5.18, P = 0.010), high levels of TC (OR = 2.15, 95 % CI: 1.03-4.48, P = 0.042), and higher doses of antidepressants (OR = 1.02, 95 % CI: 1.00-1.04, P = 0.029) were independently associated factors for hypertriglyceridemia, while high levels of HDL-C (OR = 0.11, 95 % CI: 0.04-0.31, P < 0.001) were protective factors. In addition, high levels of TC (OR = 113.94, 95 % CI: 20.01-648.85) were statistically different (P < 0.001) and suggested that the factor was significantly related to high LDL-C. Meanwhile, older age (OR = 1.25, 95 % CI: 1.02-1.52, P = 0.030) and high levels of TG (OR = 3.00, 95 % CI: 1.98-4.55, P < 0.001) were independent factors contributing to low HDL-C. Conclusion: The high prevalence of dyslipidemia in childhood and adolescence among children and adolescents with depressive disorder has become a public health issue. Hypercholesterolemia and hypertriglyceridemia showed a positive correlation with suicidal thoughts and suicidal attempts. Monitoring the incidence of suicidal thoughts and attempts among them would carry some predictor meaning in therapy and for jumping back to health.

19.
Heliyon ; 10(7): e28005, 2024 Apr 15.
Article in English | MEDLINE | ID: mdl-38689995

ABSTRACT

ARPC1B encodes the protein known as actin-related protein 2/3 complex subunit 1 B (ARPC1B), which controls actin polymerization in the human body. Although ARPC1B has been linked to several human malignancies, its function in these cancers remains unclear. TCGA, GTEx, CCLE, Xena, CellMiner, TISIDB, and molecular signature databases were used to analyze ARPC1B expression in cancers. Visualization of data was primarily achieved using R language, version 4.0. Nineteen tumors exhibited high levels of ARPC1B expression, which were associated with different tumor stages and significantly affected the prognosis of various cancers. The level of ARPC1B expression substantially connected the narrative of ARPC1B expression with several TMB cancers and showed significant changes in MSI. Additionally, tolerance to numerous anticancer medications has been linked to high ARPC1B gene expression. Using Gene Set Variation Analysis/Gene Set Enrichment Analysisanalysis and concentrating on Rectum adenocarcinoma (READ), we thoroughly examined the molecular processes of the ARPC1B gene in pan-cancer. Using WGCNA, we examined the co-expression network of READ and ARPC1B. Meanwhile, ten specimens were selected for immunohistochemical examination, which showed high expression of ARPC1B in READ. Human pan-cancer samples show higher ARPC1B expression than healthy tissues. In many malignancies, particularly READ, ARPC1B overexpression is associated with immune cell infiltration and a poor prognosis. These results imply that the molecular biomarker ARPC1B may be used to assess the prognosis and immune infiltration of patients with READ.

20.
Front Pharmacol ; 15: 1377836, 2024.
Article in English | MEDLINE | ID: mdl-38818379

ABSTRACT

Testicular torsion is a critical urologic condition for which testicular detorsion surgery is considered irreplaceable as well as the golden method of reversal. However, the surgical treatment is equivalent to a blood reperfusion process, and no specific drugs are available to treat blood reperfusion injuries. Salidroside (SAL) is one of the main effective substances in rhodiola, which has been shown to have antioxidant and antiapoptosis activities. This study was designed to determine whether SAL exerted a protective effect on testicular ischemia-reperfusion (I/R) injury. In this study, the I/R injury model of the testes and reoxygenation (OGD/R) model were used for verification, and SAL was administered at doses of 100 mg/kg and 0.05 mmol/L, respectively. After the experiments, the testicular tissue and TM4 Sertoli cells were collected for histopathologic and biochemical analyses. The results revealed that SAL improves the structure of testicular tissue and regulates the oxidation-antioxidation system. To further understand the molecular mechanisms of SAL in treating testicular I/R injuries, transcriptomics and metabonomics analyses were integrated. The results show that the Nfr2/HO-1/GPX4/ferroptosis signaling pathway is enriched significantly, indicating that it may be the main regulatory pathway for SAL in the treatment of testicular I/R injuries. Thereafter, transfection with Nrf2 plasmid-liposome was used to reverse verify that the Nfr2/HO-1/GPX4/ferroptosis signaling pathway was the main pathway for SAL anti-testicular I/R injury treatment. Thus, it is suggested that SAL can protect against testicular I/R injuries by regulating the Nfr2/HO-1/GPX4 signaling pathway to inhibit ferroptosis and that SAL may be a potential drug for the treatment of testicular I/R injuries.

SELECTION OF CITATIONS
SEARCH DETAIL
...